$0.597
+0.027 (+4.59%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
HUMA 相似圖表分析預測
Alphio's HUMA stock price prediction model matches the current Humacyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.60 (-0.21%). The 1-week path is $0.60 (+0.99%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Humacyte Inc 股票嗎？
Humacyte Inc is currently priced at $0.6501, which is significantly below the analyst price targets of $1 to $4, indicating potential upside. However, the company has a high forward P/E of 35.84, suggesting that it may be overvalued relative to its earnings potential. Additionally, the recent RSI of 45.646 indicates that the stock is neither overbought nor oversold, suggesting caution. The main risk is the company's significant net income loss of -36802000 in Q2 2026, which raises concerns about its financial health.
HUMA 股價於 Wednesday 收在 $0.60，此前上漲 +4.59%
Humacyte Inc (HUMA) last closed at $0.5966, gaining +4.59%. These facts feed the 1-day and 1-week HUMA price prediction above.
預測驅動因素
Humacyte Inc（HUMA）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 HUMA 最接近的股票，依相似度排序。
HUMA 季節性分析
Historically the probability of a positive September return for HUMA is 46.51%. February offers the highest probability of a positive month at 62.07%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。